L. Neil Hunn

Board

Since August 2018

Age

52 years

Tenure

Joined ROP in 2011 and served first as Group Vice President of the medical segment, later becoming Executive Vice President and Chief Operating Officer in 2017 before assuming the role of President and Chief Executive Officer in August 2018.

Also at ROPER TECHNOLOGIES

JPC

Jason P. Conley

EVP and CFO

JKS

John K. Stipancich

EVP, General Counsel, and Corporate Secretary

About

L. Neil Hunn was born in 1972, and by his early fifties he has established a strong reputation as a dynamic leader in the technology and healthcare sectors. With his background in leading financial and operational functions, he has consistently demonstrated a focus on growth, strategic planning, and capital deployment across his career.

Before joining ROP, he spent a decade at MedAssets, Inc., where he held key positions including Executive Vice President, Chief Financial Officer, and President of the revenue cycle technology businesses, successfully navigating an initial public offering and various mergers and acquisitions. His earlier professional experiences at companies such as CMGI, Inc. and Parthenon Group further enriched his expertise in technology and strategic consulting.

Upon joining ROP in 2011, his contributions quickly became evident as he played a pivotal role in the expansion of the company’s medical segment. His career progression—from Group Vice President to Executive Vice President and Chief Operating Officer, and ultimately to President and CEO—underscores his ability to lead transformative initiatives and drive operational excellence. Beyond his executive roles at ROP, he has also been serving as a director of Deere & Company since 2023, broadening his leadership impact across industries.

$ROP Performance Under L. Neil Hunn

Past Roles

Organization	Role	Date Range	Details
Roper Technologies, Inc.	Executive Vice President and Chief Operating Officer	2017–2018	Oversaw operations and drove strategic growth initiatives
Roper Technologies, Inc.	Group Vice President of Medical Segment	2011–2018	Led medical technology and application software businesses
MedAssets, Inc.	Executive Vice President, Chief Financial Officer, and later President of revenue cycle technology businesses	N/A	Led IPO and executed several M&A transactions; 10 years tenure
CMGI, Inc.	Various roles	N/A	Incubator of Internet businesses
Parthenon Group	Consultant	N/A	Strategy consulting firm experience

External Roles

Organization	Role	Date Range	Details
Deere & Company	Director	Since 2023	Global leader in agricultural, construction, and forestry equipment

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$1,000,000	2023	Fixed annual base salary
Club Memberships	$11,931	2023	Incremental cost to the company
Personal Use of Aircraft	$225,000	2023	Incremental cost to the company
Company Car	$24,000	2023	Incremental cost to the company
Additional Medical Services	$4,500	2023	Incremental cost to the company
Financial Planning	$21,780	2023	Incremental cost to the company
Contributions to Defined Contribution Plans	$225,000	2023	Includes contributions to the Non-Qualified Retirement Plan and 401(k)

Performance Compensation

Data from FY 2023

Performance-Based Equity Incentive Awards

Metric	Details
Performance Metric	Adjusted EBITDA measured cumulatively over a 36-month period (January 2023 – December 2025)
Threshold	$6.517 billion at which 17.5% of the award vests
Target	$6.917 billion at which 50% of the award vests, with pro-rata vesting between threshold and target
Vesting Schedule	Vests in March 2026, contingent upon performance certification by the Compensation Committee
Grant Date	March 14, 2023
Grant Date Fair Value (Stock Awards)	$13,982,907
Grant Date Stock Price	$428.07 per share
Number of Shares Granted	32,665 shares
Vesting Conditions	Performance criteria based on cumulative adjusted EBITDA must be met; dividends on restricted shares are paid only if the performance criteria are achieved

This table outlines the detailed performance compensation components including metrics, thresholds, targets, vesting schedule, evaluation period, and key grant details for 2023.